2-hexynyladenosine-5'-n-ethylcarboxamide has been researched along with cangrelor in 1 studies
| Studies (2-hexynyladenosine-5'-n-ethylcarboxamide) | Trials (2-hexynyladenosine-5'-n-ethylcarboxamide) | Recent Studies (post-2010) (2-hexynyladenosine-5'-n-ethylcarboxamide) | Studies (cangrelor) | Trials (cangrelor) | Recent Studies (post-2010) (cangrelor) |
|---|---|---|---|---|---|
| 28 | 0 | 2 | 418 | 54 | 286 |
| Protein | Taxonomy | 2-hexynyladenosine-5'-n-ethylcarboxamide (IC50) | cangrelor (IC50) |
|---|---|---|---|
| Ornithine decarboxylase | Rattus norvegicus (Norway rat) | 0.0004 | |
| P2Y purinoceptor 12 | Homo sapiens (human) | 0.0043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonda, TA; Karolczak, K; Kramkowski, K; Polak, D; Przygodzki, T; Talar, M; Watala, C; Wojkowska, DW; Wolska, N | 1 |
1 other study(ies) available for 2-hexynyladenosine-5'-n-ethylcarboxamide and cangrelor
| Article | Year |
|---|---|
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus.
Topics: Adenosine Monophosphate; Adenosine-5'-(N-ethylcarboxamide); Adult; Animals; Antithrombins; Blood Pressure; Blood-Brain Barrier; Chlorides; Diastole; Female; Ferric Compounds; Fibrinogen; Humans; Laser-Doppler Flowmetry; Male; Mice, Inbred C57BL; Permeability; Platelet Activation; Platelet Aggregation; Prasugrel Hydrochloride; Purinergic P1 Receptor Agonists; Purinergic P2Y Receptor Antagonists; Systole; Thrombosis | 2021 |